Trial Condition(s):

Contraception, Heavy Menstrual Bleeding (HMB)

Qlaira: Inhib. of CYP3A4 by ketoconazole a. erythrom

Bayer Identifier:

91391

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2005-005001-37

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

April2006

July2006

Phase

Could I receive a placebo?

Products

Natazia/Qlaira (EV/DNG, BAY86-5027)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations
Locations Bayer Pharma AG Berlin, Germany, 13353	Contact Us: E-mail: [email protected] Phone: Not Available

Bayer Pharma AG

Berlin, Germany, 13353

Contact Us:

E-mail: [email protected]

Phone: Not Available

Contraception, Heavy Menstrual Bleeding (HMB)

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

45 Years

75 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information